esophageal squamous cell carcinoma
Conditions
Interventions
The neoadjuvant chemotherapy combined with immunotherapy group:None
The neoadjuvant chemotherapy treatment group:None
Sponsors
Sun Yat-sen University Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.The age range is from 18 to 80 years old; 2.The clinical diagnosis is esophageal squamous cell carcinoma of the thoracic region (ESCC), with stage T1N1-3M0 or T2-4aN0-3M0; 3.The patients have completed neoadjuvant therapy and undergone thoracic esophagectomy; 4.The clinical data are complete and can provide comprehensive treatment information.
Exclusion criteria
Exclusion criteria: 1.Previous history of malignant tumor; 2.Incomplete neoadjuvant treatment or salvage surgery; 3.Unable to assess treatment response due to lack of examination data; 4.Missing clinical data or follow-up information.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-year progression-free survival rate and overall survival rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The recurrence and metastasis patterns 3 years after the surgery; | — |
Countries
China
Contacts
Public ContactFu Jianhua
Sun Yat-sen University Cancer Center
Outcome results
None listed